Portfolio Companies
6Ellipsis Health
Ellipsis Health raises $45M in Series A funding to expand its healthcare SaaS platform.
Stately Bio
Stately Bio raises $12M seed round
QurAlis
QurAlis raises $88M Series B to advance precision medicines for neurodegenerative diseases
Spire Global
Satellite constellation operator Spire Global going public via $1.6B SPAC merger
Inventys Thermal Technologies
Closed financing round led by Chevron Technology Ventures, Mitsui, Roda Group, and Chrysalix
Kaltura
Kaltura raised $47M from SAP Ventures, Nokia Growth Partners and others, backed by Nexus Ventures
Recent Articles
16Ellipsis Health Raises $45 Million in Series A - The SaaS News
Ellipsis Health has successfully raised $45 million in a Series A funding round, marking a significant milestone for the healthcare SaaS company as it looks to expand its platform and services.
6/17/2025
Top digital health funding: Cigna backs AI agent startup - Modern Healthcare
Cigna is among top investors backing an AI agent startup in the latest digital health funding round, highlighting growing insurer interest in AI-driven healthcare solutions.
6/13/2025
Ellipsis Health banks $45M for AI care manager, backed by Salesforce, Khosla Ventures and CVS Health Ventures - Fierce Healthcare
Ellipsis Health raised $45M to develop an AI-powered care manager, with backing from Salesforce, Khosla Ventures, and CVS Health Ventures, signaling strong investor confidence in AI-driven healthcare solutions.
6/13/2025
Ellipsis Health unveils Sage, the emotionally intelligent AI Care Manager, backed by $45M from Salesforce, Khosla Ventures, and CVS Ventures - PR Newswire
Ellipsis Health has launched Sage, an emotionally intelligent AI Care Manager, securing $45M in funding from Salesforce, Khosla Ventures, and CVS Ventures to advance AI-driven mental health care solutions.
6/12/2025
Wilson Sonsini Advises Stately Bio on $12 Million Seed Financing - Wilson Sonsini
Wilson Sonsini advised Stately Bio on a $12 million seed financing round, demonstrating the firm's continued involvement in supporting biotech startups in early-stage funding.
5/6/2025
Stately Bio Raises $12M Seed to Develop Next Generation Regenerative Medicines with ML-Powered Cellular Imaging Platform - WebWire
Stately Bio has raised $12M in seed funding to advance next-generation regenerative medicines using a machine learning-powered cellular imaging platform, aiming to transform how cells are studied and therapies developed.
5/2/2025
QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases - PR Newswire
QurAlis has successfully closed an $88 million Series B financing round aimed at advancing precision medicines for neurodegenerative diseases, marking a significant milestone in the biotech company's growth.
3/9/2023
Mitsui Chemicals explores new products with CVC launch - Global Venturing
Mitsui Chemicals has launched a corporate venture capital arm to explore and develop new products, signaling a strategic push into innovation through startup investment.
7/5/2022
Satellite constellation operator Spire Global to go public via $1.6 billion SPAC - TechCrunch
Spire Global, a satellite constellation operator, plans to go public through a SPAC deal valued at $1.6 billion, as reported by TechCrunch.
3/1/2021
The Global Public Offering Fund finds success going against the grain - Venture Capital Journal
The Global Public Offering Fund has achieved notable success by adopting a contrarian investment strategy, standing out in the venture capital landscape by going against conventional market trends.
10/26/2020
QurAlis raises $42M in Series A round to develop therapies for ALS - MedCity News
QurAlis has successfully raised $42 million in a Series A funding round aimed at advancing the development of therapies for ALS (amyotrophic lateral sclerosis), a progressive neurodegenerative disease.
5/17/2020
Private investors poured $10.5 billion into clean energy in 2019. These are the top funds making bets on the industry. - Business Insider
In 2019, private investors invested $10.5 billion into clean energy. Business Insider highlights the top funds leading these bets on the growing clean energy industry.
1/16/2020
Kaminario increases series E capacity - Global Venturing
Kaminario has expanded its Series E funding capacity, as reported by Global Venturing. The storage technology company continues to attract investor interest, boosting its capital raise in the latest funding round.
1/26/2015
Prudent Energy’s Vanadium Flow Battery - Nanalyze
An overview of Prudent Energy's vanadium flow battery technology, exploring its applications and potential in the energy storage market as analyzed by Nanalyze.
11/21/2014
Inventys Thermal Technologies Closes Financing from Chevron Technology Ventures, Mitsui, Roda Group & Chrysalix - Yahoo! Finance Canada
Inventys Thermal Technologies has successfully closed a financing round with investors including Chevron Technology Ventures, Mitsui, Roda Group, and Chrysalix, signaling strong industry backing for its thermal technology solutions.
7/30/2014
Nexus Ventures-backed Kaltura raises $47M from SAP Ventures, Nokia Growth Partners, others - VCCircle
2/12/2014
Investment Signals
20Kaltura, a video platform company backed by Nexus Ventures, raised $47M in funding from strategic investors including SAP Ventures and Nokia Growth Partners.
QurAlis secured $42M in Series A funding to develop therapies for ALS, indicating investor confidence in the company's approach to neurodegenerative disease treatment.
Kaminario has increased its Series E funding round capacity, indicating strong investor confidence and extended runway for the storage/infrastructure company.
Inventys Thermal Technologies secured financing from major strategic investors including Chevron Technology Ventures, Mitsui, Roda Group, and Chrysalix, indicating investor confidence in thermal technology solutions.
Ellipsis Health completed a $45 million Series A funding round, indicating strong investor confidence in their healthcare technology platform.
Stately Bio raised $12 million in seed financing, indicating early-stage biotech investment activity and investor confidence in the company.
Prudent Energy is developing vanadium flow battery technology, indicating VC interest in long-duration energy storage solutions for the clean energy transition.
AI-powered care management with emotional intelligence capabilities is a prioritized investment area for major healthcare and enterprise investors.
Ellipsis Health raised $45M for Sage, an AI-powered care management platform backed by major strategic investors including Salesforce, Khosla Ventures, and CVS Ventures.
VC/SPAC investors are backing satellite constellation operators as infrastructure plays for data collection and connectivity services.
Spire Global, a satellite constellation operator, is going public through a $1.6 billion SPAC merger, indicating significant growth-stage financing and market validation for space technology infrastructure.
ML-powered cellular imaging is a valuable technology for advancing regenerative medicine development.
Stately Bio raised $12M seed funding to develop regenerative medicines using ML-powered cellular imaging platform.
AI-powered care management solutions attracting significant venture capital investment from both traditional VCs and healthcare industry players.
Ellipsis Health raised $45M for AI-powered care management platform, backed by prominent VCs including Khosla Ventures and CVS Health Ventures.
Investment focus on precision medicine approaches for treating neurodegenerative diseases, indicating confidence in targeted therapeutic strategies.
QurAlis closed an $88 million Series B financing round focused on developing precision medicines for neurodegenerative diseases.
Top venture funds are actively making investment bets on the clean energy industry, suggesting it is a priority investment thesis.
Private investors deployed $10.5 billion into clean energy in 2019, indicating significant capital flow and momentum in the climate tech sector.
Growing trend of AI agents being deployed in digital health, attracting corporate healthcare investor backing.